Extensive posttreatment ganglioneuromatous differentiation of rhabdomyosarcoma: malignant ectomesenchymoma in an infant.
Sebire
Neil J
NJ
Ramsay
Alan D
AD
Malone
Marion
M
Risdon
R Anthony
RA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003893:Desmin / Q000032:analysis; D005729:Ganglioneuroma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D008048:Lip Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008637:Mesenchymoma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D017570:MyoD Protein / Q000032:analysis; D018008:Myogenin / Q000032:analysis; D016609:Neoplasms, Second Primary / Q000473:pathology*; D012208:Rhabdomyosarcoma / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*
D014408:Biomarkers, Tumor; D003893:Desmin; C503799:MYOG protein, human; D017570:MyoD Protein; C057363:MyoD1 myogenic differentiation protein; D018008:Myogenin